IanRabinowitzMD

Clinical Trials

• Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01

  Completed

  Phase 3

• Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 2004 Apr 01

  Completed

  Phase 1

• Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen Start of enrollment: 2004 Apr 01

  Completed

  Not Applicable

• A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec Start of enrollment: 2004 Apr 01

  Completed

  Phase 2

• Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma Start of enrollment: 2000 Sep 01

  Completed

  Phase 2

• INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. Start of enrollment: 2002 Aug 01

  Completed

  Phase 2

• Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer. Start of enrollment: 1999 Feb 01

  Terminated

• A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes Start of enrollment: 2002 Jun 01

  Completed

  Phase 3

• Dysregulated Tyrosine Kinase Signaling in Leukemia Start of enrollment: 2002 May 01

  Terminated

• Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer Start of enrollment: 2000 May 01

  Completed

  Phase 1, Phase 2

• Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01

  Active, not recruiting

  Phase 3

• Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Start of enrollment: 2008 Sep 01

  Terminated

  Phase 3

• A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML) Start of enrollment: 2009 Sep 01

  Withdrawn

  Phase 2

• Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2014 Jul 01

  Terminated

  Phase 1

• Compassionate Use of BYL 719 Alpelisib

  No longer available

• Join now to see all